Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb;42(1):101181.
doi: 10.1016/j.accpm.2022.101181. Epub 2022 Dec 6.

COVID-19: Brief overview of therapeutic strategies

Anne-Lise Beaumont  1 , Sacha Rozencwajg  2 , Nathan Peiffer-Smadja  3 , Philippe Montravers  4
Affiliations
Review

COVID-19: Brief overview of therapeutic strategies

Anne-Lise Beaumont et al. Anaesth Crit Care Pain Med. 2023 Feb.
No abstract available

Keywords: Antiviral therapies; COVID-19; Oxygen.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
COVID-19 treatment algorithm. SOT: Solid Organ Transplant. BMT: Bone Marrow Transplant. eGFR: estimated Glomerular Filtration Rate. MV: Mechanical Ventilation.
See this image and copyright information in PMC

Comment in

References

    1. Liverpool drug interactions group. (Last access: October 12, 2022). Available in: https://www.covid19-druginteractions.org/.
    1. Takashita E., Yamayoshi S., Simon V., van Bakel H., Sordillo E.M., Pekosz A., et al. Efficacy of antibodies and antiviral drugs against omicron ba.2.12.1, ba.4, and ba.5 subvariants. N Engl J Med. 2022;387:468–470. doi: 10.1056/NEJMc2207519. - DOI - PMC - PubMed
    1. Piechotta V., Iannizzi C., Chai K.L., Valk S.J., Kimber C., Dorando E., et al. Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review. Cochrane Database Syst Rev. 2021;5 doi: 10.1002/14651858.CD013600.pub4. - DOI - PMC - PubMed
    1. Lee T.C., Murthy S., Del Corpo O., Senécal J., Butler-Laporte G., Sohani Z.N., et al. Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28:1203–1210. doi: 10.1016/j.cmi.2022.04.018. - DOI - PMC - PubMed
    1. Recovery collaborative group Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021;397:1637–1645. doi: 10.1016/S0140-6736(21)00676-0. - DOI - PMC - PubMed

Substances